
News|Articles|September 1, 2003
Cardiovascular benefit of 'polypill' evaluated in BMJ
Three different drugs at half the standard dose are estimated to reduce the risk of stroke by 63% and ischemic heart disease (IHD) events by 46% for those aged 60 to 69 years, according to a study in BMJ. Another study published in the same issue recommends that those with known occlusive vascular disease and everyone aged 55 years or older take a "polypill," including the combination of blood pressure-lowering drugs, a statin, folic acid, and aspirin.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Advancing Equity and Access in Breast Cancer Care
2
Type 1 Diabetes Drug Tzield Under Expedited Review Through New FDA Program
3
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
4
Final Takeaways of the GALAXI-2 and GALAXI-3 Trials From Lead Investigators
5